SC
NXTM

Skylands Capital’s NxStage Medical Inc. NXTM Stock Holding History

Skylands Capital’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-31,300
Closed -$686K – 211
2015
Q4 		$686K Sell
31,300
-80,950
-72% -$1.51M 0.1% 139
2015
Q3 		$1.77M Sell
112,250
-77,976
-41% -$1.25M 0.24% 91
2015
Q2 		$2.72M Buy
190,226
+14,126
+8% +$239K 0.29% 77
2015
Q1 		$3.05M Buy
176,100
+5,600
+3% +$98.9K 0.31% 75
2014
Q4 		$3.06M Sell
170,500
-3,000
-2% -$48.3K 0.31% 67
2014
Q3 		$2.28M Buy
173,500
+76,642
+79% +$1.03M 0.23% 100
2014
Q2 		$1.39M Buy
96,858
+60,358
+165% +$788K 0.14% 142
2014
Q1 		$465K Sell
36,500
-2,000
-5% -$26.1K 0.05% 185
2013
Q4 		$385K Buy
38,500
+600
+2% +$6.81K 0.04% 177
2013
Q3 		$499K Buy
37,900
+9,900
+35% +$130K 0.06% 186
2013
Q2 		$400K Buy
+28,000
New +$352K 0.05% 183

Other funds holding NXTM

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Skylands Capital's NXTM Position: Q1 2016 in Review

Skylands Capital sold out of NxStage Medical Inc. (NXTM) in Q1 2016, closing a stake of 31,300 shares — an estimated $686K sold.

Skylands Capital first reported a position in NXTM in Q2 2013 and held it in 11 quarters. The position peaked at $3.06M in Q4 2014. 140 funds tracked by Wall St. Rank hold NXTM as of Q1 2016.

  • Skylands Capital reported no remaining NxStage Medical Inc. position as of Q1 2016 after selling out during the quarter.
  • Skylands Capital sold 31,300 NxStage Medical Inc. shares in Q1 2016, an estimated $686K.
  • Skylands Capital first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 11 quarters.
  • Skylands Capital's NxStage Medical Inc. position peaked at $3.06M in Q4 2014.
  • 140 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2016.

Based on Skylands Capital's 13F filing for Q1 2016, filed 14 Apr 2016.